4.7 Article

Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy

期刊

EUROPEAN HEART JOURNAL
卷 43, 期 30, 页码 2852-+

出版社

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehac268

关键词

Modifiable risk factors; Cardiovascular disease; Death; China

资金

  1. Population Health Research Institute
  2. Hamilton Health Sciences Research Institute (HHSRI)
  3. Canadian Institutes of Health Research
  4. Heart and Stroke Foundation of Ontario
  5. Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit
  6. Ontario Ministry of Health and Long-Term Care
  7. AstraZeneca (Canada)
  8. Sanofi-Aventis (France)
  9. Sanofi-Aventis (Canada)
  10. Boehringer Ingelheim (Germany)
  11. Boehringer Ingelheim (Canada)
  12. Servier
  13. GlaxoSmithKline
  14. Novartis
  15. King Pharma
  16. National Center for Cardiovascular Diseases
  17. ThinkTank Research Center for Health Development
  18. CAMS Innovation Fund for Medical Sciences [2016-I2M-2-004]
  19. Construction of Basic Information Technology Support System and Platform for National Prevention and Treatment of Cardiovascular Diseases
  20. Project of National Clinical Research Center for Cardiovascular Disease [NCRC2020002]

向作者/读者索取更多资源

China shows gender and regional disparities in cardiovascular disease and mortality rates. Significant reductions in cardiovascular disease incidence can be achieved by controlling metabolic risk factors and improving education.
Aims To examine the incidence of cardiovascular disease (CVD) and mortality in China and in key subpopulations, and to estimate the population-level risks attributable to 12 common modifiable risk factors for each outcome. Methods and results In this prospective cohort of 47 262 middle-aged participants from 115 urban and rural communities in 12 provinces of China, it was examined how CVD incidence and mortality rates varied by sex, by urban-rural area, and by region. In participants without prior CVD, population-attributable fractions (PAFs) for CVD and for death related to 12 common modifiable risk factors were assessed: four metabolic risk factors (hypertension, diabetes, abdominal obesity, and lipids), four behavioural risk factors (tobacco, alcohol, diet quality, and physical activity), education, depression, grip strength, and household air pollution. The mean age of the cohort was 51.1 years. 58.2% were female, 49.2% were from urban areas, and 59.6% were from the eastern region of China. The median follow-up duration was 11.9 years. The CVD was the leading cause of death in China (36%). The rates of CVD and death were 8.35 and 5.33 per 1000 person-years, respectively, with higher rates in men compared with women and in rural compared with urban areas. Death rates were higher in the central and western regions of China compared with the eastern region. The modifiable risk factors studied collectively contributed to 59% of the PAF for CVD and 56% of the PAF for death in China. Metabolic risk factors accounted for the largest proportion of CVD (PAF of 41.7%), and hypertension was the most important risk factor (25.0%), followed by low education (10.2%), high non-high-density lipoprotein cholesterol (7.8%), and abdominal obesity (6.9%). The largest risk factors for death were hypertension (10.8%), low education (10.5%), poor diet (8.3%), tobacco use (7.5%), and household air pollution (6.1%). Conclusion Both CVD and mortality are higher in men compared with women, and in rural compared with urban areas. Large reductions in CVD could potentially be achieved by controlling metabolic risk factors and improving education. Lowering mortality rates will require strategies addressing a broader range of risk factors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据